Researchers at Leiden University Medical Center, funded by the Bill & Melinda Gates Foundation, have unveiled a disturbing new approach to vaccine delivery—genetically modified mosquitoes acting as “flying vaccinators” that administer vaccines with or without the consent or knowledge of the subject.
In a study published in the New England Journal of Medicine, scientists demonstrated the use of Gates’ bio-engineered mosquitoes to administer malaria vaccines.
Infected with genetically modified parasites (GA1 and GA2), these mosquitoes prime the immune system without causing severe illness, with the GMO parasites programmed to halt development at a specific stage.
During the trial, the mosquitoes carrying these engineered parasites bit human test subjects in a controlled environment, effectively “vaccinating” them.
While researchers touted this as a novel method to combat malaria, the concept of using Gates’ mosquitoes as vaccine carriers has sparked significant ethical and safety concerns.
 |
| Vaccination by GMO mosquito has been described as “just like a conventional vaccination but with no pain and no cost.” |
In the trial, 43 adults aged 19 to 35 with no prior malaria history were divided into three groups. The first group received 50 bites from mosquitoes carrying the GA2 parasite, the second group received 50 bites from mosquitoes carrying the GA1 parasite, and the placebo group was bitten by uninfected mosquitoes. Participants underwent three vaccination sessions, spaced 28 days apart.
Three weeks after the final session, all participants were exposed to malaria through bites from infected mosquitoes. The results were striking: eight out of nine in the GA2 group were protected, compared to just one out of eight in the GA1 group and none in the placebo group.
This breakthrough, hailed as a technological leap by Gates and his scientists, raises profound questions about consent, control, and the potential for unintended consequences in public health.
The idea of bio-engineered mosquitoes delivering vaccines autonomously opens the door to a host of complex legal and ethical dilemmas yet to be addressed.
However, that doesn’t appear to be a concern for Bill Gates and the professors he is funding today.
Their only focus appears to be finding ways to address vaccine hesitancy and skepticism, much of which has been fueled by the disastrous COVID-19 mRNA vaccine rollout.
The idea of using mosquitoes as “flying vaccinators” isn’t new. In 2010, Japanese researcher Shigeto Yoshida engineered mosquito saliva to deliver leishmania vaccines to mice, noting that vaccination by insect was “just like a conventional vaccination but with no pain and no cost.”
